These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7026327)

  • 1. Effect of strict blood glucose control on residual B-cell function in insulin-dependent diabetics.
    Madsbad S; Krarup T; Reguer L; Faber OK; Binder C
    Diabetologia; 1981 May; 20(5):530-4. PubMed ID: 7026327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diurnal profiles of intermediary metabolites in insulin-dependent diabetes and their relationship to different degrees of residual B-cell function.
    Madsbad S; Faber OK; Binder C; Alberti KG; Lloyd B
    Acta Diabetol Lat; 1981; 18(2):115-21. PubMed ID: 7018146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual pancreatic function in insulin dependent diabetics.
    Glatthaar C; Beaven DW; Donald RA; Smith JR; Espiner EA
    Aust N Z J Med; 1982 Feb; 12(1):43-7. PubMed ID: 7044357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of two periods with intensified insulin treatment on B-cell function during the first 18 months of type 1 (insulin-dependent) diabetes mellitus.
    Krarup T; Madsbad S
    Diabete Metab; 1986 Oct; 12(5):256-60. PubMed ID: 3542618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transient effect of strict glycaemic control on B cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients.
    Madsbad S; Krarup T; Faber OK; Binder C; Regeur L
    Diabetologia; 1982 Jan; 22(1):16-20. PubMed ID: 7037505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon.
    Hendriksen C; Faber OK; Drejer J; Binder C
    Diabetologia; 1977 Dec; 13(6):615-9. PubMed ID: 338408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic B-cell response to a test-meal in lean and obese diabetic patients: relation to metabolic control.
    Daubresse JC; Bailly A; Lemy C; Meunier JC; Luyckx AS; Lefebvre PJ
    Acta Diabetol Lat; 1980; 17(3-4):247-54. PubMed ID: 7013399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
    Li X; Zhou ZG; Qi HY; Chen XY; Huang G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of immunoreactive gastric inhibitory polypeptide to changes in glycaemic control and B cell function in type 1 (insulin-dependent) diabetes mellitus.
    Krarup T; Madsbad S; Regeur L; Faber OK; Tronier B
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):221-5. PubMed ID: 6364671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-peptide measurement and its clinical usefulness: a review.
    Bonser AM; Garcia-Webb P
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):200-6. PubMed ID: 7025733
    [No Abstract]   [Full Text] [Related]  

  • 12. beta-cell function in children with diabetes.
    Ludvigsson J; Heding LG
    Diabetes; 1978; 27 Suppl 1():230-4. PubMed ID: 344114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma C-peptide response to arginine in insulin-dependent diabetic subjects.
    Giugliano D; Luyckx AS; Lefebvre PJ
    J Endocrinol Invest; 1980; 3(1):19-23. PubMed ID: 6989887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.
    Faber OK; Binder C
    Diabetes; 1977 Jul; 26(7):605-10. PubMed ID: 326604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual B-cell function in type 1 (insulin-dependent) diabetes mellitus: its relation to clinical and metabolic features.
    Bonora E; Coscelli C; Butturini U
    Acta Diabetol Lat; 1984; 21(4):375-83. PubMed ID: 6397028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. betacell function during insulin or chlorpropamide treatment of maturity-onset diabetes mellitus.
    Turner RC; Holman RR
    Diabetes; 1978; 27 Suppl 1():241-6. PubMed ID: 344115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting plus prandial insulin supplements improve insulin secretory ability in NIDDM subjects.
    Kawamori R; Bando K; Yamasaki Y; Kubota M; Watarai T; Iwama N; Shichiri M; Kamada T
    Diabetes Care; 1989; 12(10):680-5. PubMed ID: 2515048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months.
    Gérard J; Luyckx AS; Lefebvre PJ
    Diabetologia; 1981 Nov; 21(5):446-51. PubMed ID: 7028558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
    Gerö L; Korányi L; Tamás G
    Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.